Volume 59, Issue 4, Pages (April 2011)

Slides:

Advertisements

Similar presentations

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

Advertisements

Volume 60, Issue 5, Pages (November 2011)

Pascal Rischmann European Urology Supplements

Volume 53, Issue 3, Pages (March 2008)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 2, Pages (August 2010)

Volume 58, Issue 4, Pages (October 2010)

Radiofrequency Ablation vs Conventional Surgery for Varicose Veins – a Comparison of Treatment Costs in a Randomised Trial S. Subramonia, T. Lees European.

Volume 62, Issue 6, Pages (December 2012)

Volume 66, Issue 2, Pages (August 2014)

Volume 62, Issue 5, Pages (November 2012)

Volume 72, Issue 5, Pages (November 2017)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 53, Issue 5, Pages (May 2008)

Volume 52, Issue 2, Pages (August 2007)

Let the Games Begin (with EAU Approval)

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Volume 52, Issue 3, Pages (September 2007)

Prostate Cancer Epidemic in Sight?

Volume 61, Issue 3, Pages (March 2012)

Volume 45, Issue 4, Pages (April 2004)

Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer Olav Erich Yri, Trine Bjoro, Sophie D.

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Volume 53, Issue 2, Pages (February 2008)

Volume 52, Issue 1, Pages (July 2007)

Volume 66, Issue 2, Pages (August 2014)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 59, Issue 3, Pages (March 2011)

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 51, Issue 1, Pages (January 2007)

Volume 61, Issue 5, Pages (May 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 57, Issue 2, Pages (February 2010)

Volume 65, Issue 4, Pages (April 2014)

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Volume 61, Issue 6, Pages (June 2012)

Volume 61, Issue 5, Pages (May 2012)

Volume 64, Issue 4, Pages (October 2013)

Volume 58, Issue 5, Pages (November 2010)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 63, Issue 3, Pages (March 2013)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Treatment of Bacterial Urinary Tract Infections: Presence and Future

The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.

Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.

The Economic Costs of Overactive Bladder in Germany

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 50, Issue 2, Pages (August 2006)

Volume 52, Issue 5, Pages (November 2007)

Testicular Cancer Variations in Time and Space in Europe

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 72, Issue 5, Pages (November 2017)

Volume 59, Issue 4, Pages (April 2011)

Volume 52, Issue 3, Pages (September 2007)

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

Emmanuel Chartier-Kastler, Kate Davidson European Urology Supplements

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Volume 54, Issue 2, Pages (August 2008)

Volume 52, Issue 4, Pages (October 2007)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 52, Issue 2, Pages (August 2007)

Volume 67, Issue 4, Pages (April 2015)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 59, Issue 4, Pages 637-644 (April 2011) A Prospective Randomised Trial Comparing the Modified HM3 with the MODULITH® SLX-F2 Lithotripter Pascal Zehnder, Beat Roth, Frédéric Birkhäuser, Silvia Schneider, Rolf Schmutz, George N. Thalmann, Urs E. Studer European Urology Volume 59, Issue 4, Pages 637-644 (April 2011) DOI: 10.1016/j.eururo.2011.01.026 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 The CONSORT E-flowchart (HM3 lithotripter vs MODULITH® SLX-F2 lithotripter). European Urology 2011 59, 637-644DOI: (10.1016/j.eururo.2011.01.026) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 2 (a) Overall stone-free rate, stone-free rate related to initial stone size, and size of residual fragments on day 1 after ESWL treatment according to stone localisation or presence of multiple stones. (b) Overall stone-free rate, stone-free rate related to initial stone size, and size of residual fragments 3 months after ESWL treatment according to stone localization or presence of multiple stones. Included are patients with ESWL retreatments and/or adjuvant procedures for solitary kidney stones, solitary lower calyx stones and multiple stones. European Urology 2011 59, 637-644DOI: (10.1016/j.eururo.2011.01.026) Copyright © 2011 European Association of Urology Terms and Conditions